NCT04885829View on ClinicalTrials.gov

Comparative Study of 3 Tocilizumab Products in Normal Healthy Volunteeers

PHASE1CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

May 31, 2021

Primary Completion Date

May 4, 2023

Study Completion Date

May 4, 2023

Conditions
Rheumatoid ArthritisGiant Cell Arteritis
Interventions
DRUG

Tocilizumab Prefilled Syringe

0.9ml Subcutaneous pre-filled syringes containing 162mg of Tocilizumab.

Trial Locations (4)

1010

Auckland Clinical Studies Ltd (NZCR OpCo Limited), Grafton

4006

Nucleus Network, Brisbane, Brisbane

8011

Christchurch Clinical Studies Trust Ltd (NZCR OpCo Limited), Christchurch

560100

Syngene International Ltd, Bangalore

Sponsors

Lead Sponsor

Syneos Health
All Listed Sponsors
collaborator

Dr. Reddy's Laboratories Limited

INDUSTRY

lead

Syneos Health

OTHER